Otsuka Holdings Co., Ltd.

OTSKY·OTC Markets OTCPK·Healthcare
Compare
37.98+1.06 (+2.87%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close36.92
Open37.81
Day range37.5837.98
52-week range26.1140.92
Off day high0.00%
Off 52-week high−7.18%
Volume31.85K
Avg. volume (3M)43.89K
Market cap39.80B
EPS (TTM)2.33
Forward P/E23.44
P/E ratio (TTM)16.30
Dividend yield1.40% (0.5300)
Beta (5Y)-0.06
Shares outstanding1.05B
Short interest—
Earnings dateJul 29, 2025
Analyst target49.00
Profit margin14.40%

Against its peers

Compare in full ›
OTSKY ON4.F D4S.F CUP.F OFK.F AZN
Market cap 39.80B 6.28B 31.06B 65.86B 14.28B 293.14B
P/E (TTM) 16.3 15.4 20.3 24.0 21.7 26.7
Forward P/E 23.4 — 46.1 0.3 — 16.7
Price/book 2.0 1.3 3.1 5.6 10.2 5.7
Dividend yield 1.40% 3.63% 3.57% 1.93% 1.82% 1.69%
1-year change +34.06% +18.01% −17.43% −1.62% +71.74% +12.81%
Today +2.87% +4.90% +5.64% +4.33% +2.99% +2.79%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

Latest news

All OTSKY news ›
otsuka-us.com·Positive

Otsuka Presents Landmark Final Phase 3 VISIONARY Results at ASN Demonstrating VOYXACT® (sibeprenlimab-szsi) Stabilized Kidney Function and Reduced Risk of Disease Progression and Kidney Failure, Redefining Treatment Paradigm in IgA Nephropathy | Otsuka US

You will now be redirected to www.otsuka-us.com in 20 seconds. Top panel from New England Journal of Medicine, Rizk DV, Barratt J, Suzuki Y, et al, Sibeprenlimab in IgA Nephropathy ─ Final Phase 3 Trial Analysis, Volume No. 396; page…

From the 4Search news index, newest first.

In the news

8mentions in 30 days
8with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 8 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance